# Chronic Cardiac Herniation: A Peculiar Diagnosis

**Authors:** Juan D Ayala Torres, Santiago Andrés Gómez Salazar, Juan Gonzalo Vélez Zuluaga

PMC · DOI: 10.7759/cureus.56339 · Cureus · 2024-03-17

## TL;DR

A rare case of chronic cardiac herniation in a patient with a history of Still's disease is described, highlighting the importance of timely diagnosis and treatment.

## Contribution

This case report adds to the limited medical literature on chronic cardiac herniation, emphasizing diagnostic and therapeutic approaches.

## Key findings

- The patient's condition was diagnosed using imaging modalities like CT and CMR.
- Surgical pericardiectomy resolved anatomical issues but exertional dyspnea persisted.
- Late-onset cardiac herniation is rare and often presents with non-specific symptoms.

## Abstract

The presented case describes a 56-year-old male with adult-onset Still's disease, exhibiting polyserositis in 2019, who underwent pleurectomy and pericardiectomy. Despite treatment with tocilizumab and methylprednisolone, the patient developed deep vein thrombosis and pulmonary embolism in 2022, managed with apixaban. A contrast-enhanced chest tomography revealed no recurrent thromboembolic events. Over a year, the patient experienced progressive dyspnea, correlating with signs of constriction on transthoracic echocardiogram. Cardiac magnetic resonance imaging confirmed cardiac herniation, prompting pericardiectomy. Surgery led to complete resolution of anatomical alterations without heart failure or new abnormalities, although exertional dyspnea persists post-discharge. The pathophysiology of cardiac herniation involves complex mechanisms influenced by congenital or acquired factors, resulting in abnormal heart protrusion. Medical literature highlights varied presentations, with acute cases typically post-thoracic surgeries, while late-onset cases are less common. Imaging modalities like computed tomography (CT) and cardiac magnetic resonance (CMR) aid diagnosis, emphasizing interdisciplinary collaboration. Despite challenges posed by its rarity, timely diagnosis and treatment are crucial for favourable outcomes, demonstrating the importance of considering this entity in clinical practice.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741), apixaban (PubChem CID 10182969)
- **Diseases:** adult-onset Still's disease (MONDO:0019355), pulmonary embolism (MONDO:0005279), heart failure (MONDO:0005252)

## Full-text entities

- **Diseases:** pulmonary embolism (MESH:D011655), deep vein thrombosis (MESH:D020246), polyserositis (MESH:D010505), Still's disease (MESH:D016706), Cardiac Herniation (MESH:D006331), heart failure (MESH:D006333), dyspnea (MESH:D004417), thromboembolic (MESH:D013923)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11023520/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11023520/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC11023520/full.md

---
Source: https://tomesphere.com/paper/PMC11023520